Z-WEHD-FMK: Irreversible Caspase-5 Inhibitor for Inflammation and Pathogenesis Research

Executive Summary: Z-WEHD-FMK (CAS 210345-00-9) is a selective, irreversible inhibitor of inflammatory caspases, including caspase-1, -4, and -5, widely applied in inflammation and infectious disease research (APExBIO). It prevents caspase-mediated cleavage of target proteins, including golgin-84, and thus disrupts Chlamydia-induced Golgi fragmentation and bacterial proliferation (Padia et al. 2025). The compound is cell-permeable and exhibits high solubility in DMSO and ethanol but is insoluble in water, necessitating proper solvent selection. Typical use involves 80 μM treatment in HeLa cells for 9 hours, yielding a ~2-log reduction in Chlamydia infectivity. Z-WEHD-FMK’s unique mechanism and specificity enable precise dissection of caspase-driven processes, surpassing non-selective inhibitors or genetic knockdown approaches (see related article).

Biological Rationale

Inflammatory caspases (caspase-1, -4, -5 in humans) are central to the regulation of pyroptosis, a pro-inflammatory programmed cell death pathway critical in host defense and disease (Padia et al. 2025). Caspase-1 is activated by canonical inflammasomes (e.g., NLRP3, AIM2), while caspase-4 and -5 respond to cytosolic lipopolysaccharide in non-canonical pathways. Activation of these caspases triggers cleavage of gasdermin D (GSDMD), producing membrane pores and cell lysis. In disease models, aberrant caspase activation promotes pathological inflammation, tissue damage, and supports microbial pathogenesis. Selective inhibition is essential to unravel the distinct contributions of each caspase isoform, which cannot be achieved by pan-caspase inhibitors. Z-WEHD-FMK, a tetrapeptide-based irreversible inhibitor, provides the specificity required for such mechanistic studies (see practical guidance).

Mechanism of Action of Z-WEHD-FMK

Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) acts as an irreversible, cell-permeable inhibitor of caspase-1, -4, and -5 by covalently modifying the active-site cysteine residue. The fluoromethyl ketone (FMK) moiety forms a stable thioether bond with the enzyme, permanently disabling enzymatic activity (Padia et al. 2025). This inhibition blocks downstream proteolytic cascades, including cleavage of GSDMD and golgin-84. In the context of Chlamydia infection, Z-WEHD-FMK prevents caspase-dependent fragmentation of the Golgi apparatus, which is essential for efficient bacterial replication and lipid trafficking (see extension analysis). Unlike reversible inhibitors, Z-WEHD-FMK’s covalent mechanism ensures persistent inhibition during experimental windows, reducing the need for repeated dosing.

Evidence & Benchmarks

• Z-WEHD-FMK irreversibly inhibits human caspase-1, caspase-4, and caspase-5 in vitro and in cell-based assays (Padia et al. 2025).
• Application of 80 μM Z-WEHD-FMK to Chlamydia trachomatis-infected HeLa cells for 9 hours blocks golgin-84 cleavage and reduces bacterial infectivity by approximately 2 logs (Padia et al. 2025).
• The compound shows excellent cell permeability and is highly soluble in DMSO (≥46.33 mg/mL) and ethanol (≥26.32 mg/mL, with ultrasonic assistance), but is insoluble in water (APExBIO).
• Z-WEHD-FMK prevents pyroptosis induced by excess caspase-1 activation, as demonstrated in lung cancer cell models where genetic knockdown of HOXC8 led to cell death that was blocked by caspase-1 inhibition (Padia et al. 2025).
• Compared to pan-caspase inhibitors, Z-WEHD-FMK offers superior specificity for inflammatory caspases, minimizing off-target effects on apoptotic caspases (comprehensive review).

Applications, Limits & Misconceptions

Z-WEHD-FMK is widely employed in inflammation research, apoptosis assays, and infectious disease models. Notable applications include:

• Dissecting the role of caspase-1, -4, and -5 in pyroptosis and inflammatory signaling.
• Investigating Chlamydia pathogenesis by blocking caspase-mediated Golgi fragmentation.
• Screening for modulators of caspase signaling pathways in cancer, infectious, and autoimmune diseases.
• Studying the effects of caspase inhibition on host-pathogen interactions and cell death modalities.

Common Pitfalls or Misconceptions

• Z-WEHD-FMK does not inhibit apoptotic caspases (e.g., caspase-3, -7) with high efficiency—it is designed for inflammatory caspases only.
• It is not suitable for water-based formulations; attempts to dissolve in aqueous buffers will fail due to insolubility.
• Long-term storage of Z-WEHD-FMK solutions is discouraged—prepare fresh aliquots for each experiment to ensure potency.
• The inhibitor does not reverse established proteolytic damage—it must be administered prior to or concurrent with caspase activation.
• Not effective in models where caspase-independent mechanisms predominate (e.g., necroptosis, ferroptosis).

This article extends previous overviews (Z-WEHD-FMK: Irreversible Caspase Inhibitor for Inflammation) by providing freshly benchmarked quantitative results and clarifies the compound’s selectivity versus pan-caspase inhibitors. For advanced workflow design, see scenario-driven guidance, which this article updates with recent cell-based assay data.

Workflow Integration & Parameters

Preparation: Dissolve Z-WEHD-FMK in DMSO (≥46.33 mg/mL) or ethanol (≥26.32 mg/mL, with ultrasound). Avoid water. Store powder at -20°C. Prepare working aliquots fresh for each use.

Experimental Conditions: For inhibition of Chlamydia-induced Golgi fragmentation, treat infected HeLa cells with 80 μM Z-WEHD-FMK for 9 hours at 37°C in standard culture media (Padia et al. 2025).

Controls: Include vehicle-only and untreated controls. Consider parallel use of pan-caspase or non-selective inhibitors to compare specificity.

Detection: Assess caspase activity by cleavage assays or immunoblotting for substrate proteins (e.g., golgin-84, GSDMD). For Chlamydia assays, measure bacterial inclusion formation and infectious yield.

Safety and Handling: Use standard laboratory PPE. Dispose of solutions according to institutional guidelines for DMSO/ethanol-based reagents.

For further optimization strategies and troubleshooting, see the Z-WEHD-FMK product page at APExBIO.

Conclusion & Outlook

Z-WEHD-FMK (SKU A1924, APExBIO) is a validated, robust tool for dissecting inflammatory caspase function in cellular models of pyroptosis and microbial pathogenesis. Its irreversible, cell-permeable nature and selectivity for caspase-1, -4, and -5 make it uniquely suited for mechanistic studies in inflammation and pathogen-host interactions. Continued application in cancer and infectious disease models is expected to clarify the therapeutic potential of targeted caspase inhibition. For more detailed mechanistic context, see the review at Decoding Inflammatory Caspases, which this article updates with product-specific parameters and recent peer-reviewed data.